Ann: Investor Update, page-3

Well, put down the glasses folks .... no exciting anns just round the corner. (I mean, like this week).

Interesting that the glioblastoma mouse trial is simply reported as 'progressing' with no reporting timeline given. (c.f. previously end of this quarter, which it was obviously never going to be anyway.)

Good report though. Very happy to see that the previously reported (July '18) preliminary pharmacokinetic data has finally been updated. All good on that front apparently.

So, IMO, just hang in there folks. Things are going swimmingly and good fortune will befall those with patience.